Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET).

v1

Jennifer A. Chan, Jason E. Faris, Janet E. Murphy, Lawrence S. Blaszkowsky and 6 more

Type:Journal Article

Sign in to see the full record

Creating an account is free.

For data access, contact info@nobleid.org.